{"title": "Merck's Ebola vaccine tees up FDA date, aiming for first status", "author": "Nick Paul Taylor", "url": "https://www.fiercebiotech.com/biotech/fda-sets-march-pdufa-date-for-merck-ebola-vaccine", "hostname": "fiercebiotech.com", "description": "The FDA has accepted an application for approval of Merck's Ebol | Merck will learn whether the FDA will approve its Ebola vaccine V920 by mid-March, giving it a shot at becoming the first company to receive clearance to sell a vaccine against the virus in the U.S.", "sitename": "FierceBiotech", "date": "2019-09-17", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Subscribe Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}